| SciPort RLP

2015 - 2017

Moving towards precision urologic oncology

Dr. Hendrick,
Prof. Dr. Martin

2015 - 2018

Prognostic Significance of Fuhrman Grade and Age for Cancer-Specific and Overall Survival in Patients with Papillary Renal Cell Carcinoma: Results of an International Multi-Institutional Study on 2189 Patients

Dr. Hendrick,
PD Dr. Sabine

2015 - 2017

191622-120

PD Dr. Andreas,
Dr. Martin,
PD Dr. Wolfgang,
Nadine

2015 - 2017

191622-121

PD Dr. Andreas

2015 - 2017

BAY 16996

PD Dr. Wolfgang,
Prof. Dr. Christian

2015 - 2016

ERA 223 Bayer 15396

PD Dr. Wolfgang,
PD Dr. Matthias,
Univ.-Prof. Dr. Mathias

2015 - 2017

Histone deacetylase (HDAC) inhibition – A therapy concept to revoke temsirolimus resistance in urinary bladder cancer?

PD Dr. Eva

2015 - 2018

Tumor immune escape mechanisms for therapy-resistant renal cell carcinoma

PD Dr. Eva

2015 - 2016

Protein Kinase C als zentraler Regulator der Progression des Nierenzellkarzioms und als potentielles therapeutisches Ziel

Prof. Dr. Walburgis

2015 - 2018

Additive application of the natural histone acetylase (HDAC) inhibitors sulforaphane – A strategy for the avoidance of therapy resistance against everolimus in renal cell carcinoma?

PD Dr. Eva

Klinik und Poliklinik für Urologie und Kinderurologie

Klinikum / Johannes Gutenberg-Universität Mainz

Starten Sie Ihre Suche...

Klinik und Poliklinik für Urologie und Kinderurologie

Klinikum / Johannes Gutenberg-Universität Mainz